ERIN MCMURTREY: Open Payments
NPI 1437638780 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 34 payments from 9 companies in 2025. Trend: 2023 $1,204 · 2024 $1,145 · 2025 $1,194
Food & beverage: $1,190Education: $4
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $448 |
| Alkermes, Inc. | 8 | $309 |
| ABBVIE INC. | 4 | $160 |
| Neurocrine BioSciences, Inc. | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Lundbeck LLC | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: INVEGA SUSTENNA, LYBALVI, VRAYLAR, INGREZZA, COBENFY, VIVITROL, ABILIFY ASIMTUFII, UZEDY.
Industry payments across TX — which companies pay providers there.
